Surgical Science (Q4 Review): Must continue to regain confidence - Redeye

Surgical Science delivered a decent but slightly soft Q4, facing near-term headwinds from the Intuitive reset while trading at deeply undemanding valuation multiples that leave limited downside but require renewed investor confidence to unlock upside.

Länk till analysen i sin helhet: https://www.redeye.se/research/1153003/surgical-science-q4-review-must-continue-to-regain-confidence?utm_source=finwire&utm_medium=RSS